BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
Reuters2026/09/15 00:19- BIG Impact Inc completed an investment in AOI Biosciences, a Japan-based diagnostics and drug-discovery company focused on autoimmune diseases.
- AOI Biosciences commercializes proprietary antibody testing with domestic and overseas medical institutions.
- The company is building a drug-discovery platform using quantum-related technology, targeting autoimmune disease and infectious disease programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: The current Crypto Fear & Greed Index is 68, indicating a state of greed.
The global autonomous driving battle intensifies! Alphabet's Waymo teams up with a Japanese giant to seize the Tokyo market.
Waymo, a subsidiary of Alphabet, announced a partnership with a major Japanese taxi company to launch autonomous driving services in Tokyo in 2027. Following the news, shares of its partner, Go, surged by 9.7%.
Treasury Firms Stack Ethereum, Solana, and Bitcoin Through a Jittery September Market
UOB Kay Hian: Maintains "Buy" rating for Waterdrop (WDH.US), raises target price to $2.23
Based on revised profit forecasts, UOB Kay Hian has maintained its “Buy” rating on Waterdrop and raised the target price to $2.23.
Crypto prices
More
